FDA Spies on its Own

The federal agency's surveillance of staffers feared to be leaking confidential information about medical devices was wider than previously thought.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The US Food and Drug Administration conducted thorough surveillance on its own scientists in an effort to stop leaks of sensitive information pertaining to approved medical devices that the staffers feared were capable of damaging public health. While the FDA was previously known to capture screenshots of emails sent by its staff, newly public documents show that the probe was much wider, with more than 80,000 pages of information collected from the computers of scientists working within the agency. The documents also listed names—including 21 FDA staff members, members of Congress, journalists, and external researchers—of people the FDA claimed were colluding to spread negative information about the agency.

The dispute between the FDA and its own scientists started in 2008 when members of a review committee complained to members of Congress that the agency approved some cancer screening devices against the advice of the committee, which had warned that the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development